Table S2 from TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy

crossref(2023)

引用 0|浏览2
暂无评分
摘要

Cytotoxicity effects of 5-FU, FdUrd, and paclitaxel in combination with TAS-114 in various human cancer cell lines

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要